Matthew Boyd

Check out our newest episode of Boyd Biomedical Design Stories now! boydbiomedical.com/boyd-biomedica… On this episode we are joined by @BryanDechairo and @juliegarlikov from @Sherlock_Bio. We discuss their approach to molecular diagnostics using CRISPR, synthetic biology, and AI.

Be Clear This is important because we value communication, and we recognize how difficult it can be. Being clear is how we build powerful relationships with each other. And those relationships help us accomplish great things together.

Companies must acquire the ability to design, build, and launch products and services all along the patient journey. This will require multidisciplinary capabilities across a broad range of skills. Build capabilities and leverage strong partnerships.

Be True We believe the quality of our character matters. Ethics and virtue are developed through learning and practice. We revere honesty, courage, compassion, generosity, loyalty and fairness, and practice them every day.

2021 was the first year that new modalities, rather than conventional small molecules, were responsible for more than half of future projected biopharma revenues.* - *Industry Report on New Drug Modalities, Boston Consulting Group

Companies must acquire the ability to design, build, and launch products and services all along the patient journey. This will require multidisciplinary capabilities across a broad range of skills. Build capabilities and leverage strong partnerships.

On Point: Life Sciences Industry Bryan Dechairo on open-source product development enabled by AI. - Watch the full episode bit.ly/3NfaslB @Sherlock_Bio @MassMEDICouncil

What moves the needle in advanced diagnostics is the product's ability to inform clinical decisions - 'clinical utility'.* - Our growth services by helping our clients design, build, and launch diagnostic devices. - *Bringing Advanced Diagnostics to Market, BCG

Whatever you are doing - keep going. The counterfeit innovator is wildly self-confident. The real one is scared to death.* - *Steven Pressfield, The War of Art

On Point: Life Sciences Industry Bryan Dechairo on open-source product development enabled by AI. - Watch this video bit.ly/3NdN5sW Watch the full episode bit.ly/41aWBTg @Sherlock_Bio @MassMEDICouncil

On: Biomaterials Biomaterials play an essential role in healthcare today and provide critical functionality across a broad range of applications. Read more… bit.ly/41gsVEr Be Curious bit.ly/46KDiBv

Our vision is – to advance health care together. If you're working on a biomedical innovation - join us. And let us help you bring your biomedical innovation best to market.

On Point: Innovation & Startups Bryan Dechairo on his role as a Life Science's CEO. - Watch this video bit.ly/46JeRV4 Watch the full episode bit.ly/3uRK8Yl @Sherlock_Bio @MassMEDICouncil

On: Biomaterials - 32 million Americans, about 10% of the population, have an implanted medical device. And that is just a fraction of the total clinical applications where biomaterials are used today. Read more… bit.ly/4adUQZG Be Curious bit.ly/3uIwxCH

On Point: Healthcare Bryan Dechairo on his investors' focus on global health. - Watch this video bit.ly/47Y60Qa Watch the full episode bit.ly/3uKyDSJ @Sherlock_Bio @MassMEDICouncil

What does it take to commercialize biomedical innovation? - We explore this in our video series - Boyd Biomedical Design Stories. Check out our latest episodes and subscribe to stay tuned for updates. - Be curious.

On: Biomaterials Understanding the current applications of biomaterials. Biomaterials play an essential role in healthcare today and provide critical functionality across a broad range of applications. Read more… bit.ly/47OalG2 Be Curious bit.ly/3Tz7ahl

On Point: Healthcare Bryan Dechairo on bending the curve on population health. - Watch the full episode bit.ly/484rsD0 @Sherlock_Bio @MassMEDICouncil

Core Value #5 - Be Balanced Every day we work to help the best companies in the world design, build, and launch breakthrough innovations. As a team member, you are directly engaged in this pursuit on day one. You have to bring balance to big challenges.

n: Biomaterials - From orthopedics to advanced imaging, biomaterials have become the backbone of biomedical innovation. Read more… bit.ly/47TcrV5 Be Curious bit.ly/46Qnugx

2021 was the first year that new modalities, rather than conventional small molecules, were responsible for more than half of future projected biopharma revenues.* - *Industry Report on New Drug Modalities, Boston Consulting Group